Chemical formula: C₃₂H₄₀BrN₅O₅ Molecular mass: 654.595 g/mol PubChem compound: 31101
Bromocriptine is indicated for:
Population group: only adults (18 years old or older)
In the treatment of idiopathic Parkinson’s Disease, bromocriptine has been used both alone and in combination with Levodopa in the management of previously untreated patients and those disabled by ‘on-off’ phenomena. Bromocriptine has been used with occasional benefit in patients who do not respond to or are unable to tolerate Levodopa and those whose response to Levodopa is declining.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)
To reduce tumour size, particularly in those at risk of optic nerve compression.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 - 65 years old)
Bromocriptine has been used in a number of specialised units, as an adjunct to surgery and/or radiotherapy to reduce circulating growth hormone in the management of acromegalic patients.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: women, only adults (18 - 65 years old)
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: women, only adults (18 - 65 years old)
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 years old or older)
The treatment of hyperprolactinaemia in men and women with hypogonadism and/or galactorrhoea.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 years old or older)
To reduce tumour size, particularly in those at risk of optic nerve compression.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 years old or older)
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adults (18 - 65 years old)
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Bromocriptine is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
